Scienture Holdings, Inc.
SCNX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001382574
No open-market purchases or sales by Scienture Holdings, Inc. insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $709.1K in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Scienture Holdings, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 8 | 11 | +3 |
| Shares | 107.2K | 449.5K | +342.3K (+319.3%) |
| Value | $111.9K | $381.8K | +$269.8K (+241.1%) |
New holders (4)
Institutions that held Scienture Holdings, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| UBS Group AG | 114,351 | $97.2K | 0.00% |
| Private Advisor Group, LLC | 15,002 | $12.7K | 0.00% |
| Northern Trust Corp | 12,747 | $10.8K | 0.00% |
| Citigroup Inc | 503 | $427 | 0.00% |
Sold out (1)
Institutions that held Scienture Holdings, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| JPMorgan Chase & Co | 14 | $15 |